Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 12, 1998, Pages 690-694

  Huober, J ^a   Schneeweiss, A ^a   Hohaus, S ^a   Wittmann, G ^a   Meyer, A ^a   Martin, S ^a   Goldschmidt, H ^a   Bastert, G ^a   Haas, R ^a   Wallwiener, D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Breast cancer; Chemotherapy; Transplantation

Indexed keywords

CARBOPLATIN; EPIRUBICIN; IFOSFAMIDE; THIOTEPA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MUCOSA INFLAMMATION; NEUROPATHY; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARBOPLATIN; EPIRUBICIN; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IFOSFAMIDE; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; SURVIVAL ANALYSIS; THIOTEPA;

EID: 0032410892     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050233     Document Type: Article

References (17)

1. Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, Frei III E (1992) A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 10:102-110
2. Ayash LJ, Elias A, Schwartz G, Wheeler C, Ibrahim J, Teicher BA, Reich E, Warren D, Lynch C, Richardson P, Schnipper L, Frei III E, Antman K (1996) Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin. J Clin Oncol 14:2984-2992
3. Bezwoda WR (1997) Toward more active chemotherapy regimens: high-dose chemotherapy in the treatment of metastatic breast cancer. Breast J 3 (Suppl):69-76
4. Bezwoda WR (1997) High-dose chemotherapy with hematopoietic rescue in breast cancer: from theory to practice. Cancer Chemother Pharmacol 40 [Suppl]:79-87
5. Bitran JD, Samuels B, Klein L, Hanauer S. Johnson L, Murtinec J Harris E, Kempler J, White W (1996) Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. Bone Marrow Transplant 17:157-162
6. Broun ER, Sridhara R, Sledge GW, Loesch D, Kneebone PH, Hanna M, Hromas R, Cornetta K, Einhorn LH (1995) Tandem autotransplantation for the treatment of metastatic breast cancer J Clin Oncol 13:2050-2055
7. Buzdar AU, Holmes FA, Hortobagyi GN (1995) Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center Experience. Semin Oncol 22:101-104
8. Cagnoni PJ, Scott S, Bearman I, Matthes S, Ross M, Taffs S, Jones RB (1996) Paclitaxel-containing high-dose chemotherapy: the University of Colorado experience. Semin Oncol 23:43-48
9. Cameron DA, Craig J, Gabra H, Lee L, MacKay J, Parker AC, Leonard RCF (1996) High-dose chemotherapy supported by peripheral progenitor cells in poor prognosis metastatic breast cancer-a phase I/II study. Br J Cancer 74:2013-2017
10. Cold S, Jensen NV, Brinker H, Rose C (1993) The influence of chemotherapy on survival after recurrence in breast cancer-a population-based study of patients treated in the 1950s, 1960s and 1970s. Eur J Cancer 8:1146-1152
11. Dunphy FR, Spitzer G, Rossiter JE, Yau JC, Huan SD, Dicke KA, Buzdar AU, Hortobagy GN (1994) Factors predicting long-term survival for metastatic breast cancer patients with high-dose chemotherapy and bone marrow support. Cancer 73:2157-2167
12. Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, Spreafico C, Laffranchi A, Caraceni A, Martini C, Stefanelli M, Valagussa P, Bonnadonna G (1995) Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 13:2688-2699
13. Greenberg PAC, Hortobagy GN, Smith TL, Ziegler LD, Frye D, Buzdar AU (1996) Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14:2197-2205
14. Peters WP, Dansey R (1997) New concepts in the treatment of breast cancer using high-dose chemotherapy. Cancer Chemother Pharmacol 40 [suppl]:88-93
15. Somlo G, Dorhovv JH, Forman SJ, Odom-Maryon T, Lee J, Chow W, Hamasaki V, Leong L, Morgan R, Margolin K, Raschko J, Shibata S, Tetef M, Yen Y, Simpson J, Molina A (1997) High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival. J Clin Oncol 15:2882-2893
16. Tokuda Y, Ohta M, Okumura A, Kuge S, Kubota M, Tajima A, Mitomi T (1997) High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer. Cancer Chemother Pharmacol 40 [suppl]:94-99
17. Vries EGE de, Rodenhuis S, Schouten HC, Hupperets PSGJ, Dolsma WV, Lebesque JV, Blijham GH, Bontenbal M, Mulder NH (1996) Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer. Breast Cancer Res Treat 39:307-313